Soy food intake and risk of lung cancer: Evidence from the shanghai womens health study and a meta-analysis

American Journal of Epidemiology

Volumn 176, Issue 10, 2012, Pages 846-855

  Gong, Yang ^a   Shu, Xiao Ou ^a   Chow, Wong Ho ^a   Zhang, Xianglan ^a   Li, Hong Lan ^a   Ji, Bu Tian ^a   Hui, Cai ^a   Wu, Shenghui ^a   Gao, Yu Tang ^a   Wei, Zheng ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cohort studies; lung neoplasms; meta analysis; risk; soy foods; women

Indexed keywords

ISOFLAVONE;

CANCER; ESTROGENIC COMPOUND; FOOD CONSUMPTION; FOOD INTAKE; HETEROGENEITY; META-ANALYSIS; RISK FACTOR; TUMOR; WOMENS HEALTH;

ADULT; AGED; CANCER INCIDENCE; CANCER RISK; CHINA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD INTAKE; GROUPS BY AGE; HUMAN; INTERVIEW; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; META ANALYSIS; PROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SOYBEAN; SURVIVAL RATE;

ADULT; AGED; CHINA; EATING; FEMALE; HUMANS; ISOFLAVONES; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SOY FOODS;

CHINA; SHANGHAI;

EID: 84869029242     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws168     Document Type: Review

References (37)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Couse JF, Lindzey J, Grandien K, et al. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER?) and estrogen receptor-beta (ER?) messenger ribonucleic acid in the wild-type and ER?-knockout mouse. Endocrinology. 1997;138(11):4613-4621.
3. Dougherty SM, Mazhawidza W, Bohn AR, et al. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr Relat Cancer. 2006;13(1):113-134.
4. Wu CT, Chang YL, Shih JY, et al. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg. 2005;130(4):979-986.
5. Stabile LP, Davis AL, Gubish CT, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002;62(7):2141-2150.
6. Weinberg OK, Marquez-Garban DC, Fishbein MC, et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005;65(24):11287-11291.
7. Chlebowski RT, Schwartz AG, Wakelee H, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet. 2009;374(9697): 1243-1251.
8. Bouchardy C, Benhamou S, Schaffar R, et al. Lung cancer mortality risk among breast cancer patients treated with antiestrogens. Cancer. 2011;117(6):1288-1295.
9. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997;29(2):95-120.
10. Taylor CK, Levy RM, Elliott JC, et al. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev. 2009;67(7): 398-415.
11. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139(10):4252-4263.
12. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med. 2003;348(7):618-629.
13. Duffy C, Perez K, Partridge A. Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin. 2007;57(5): 260-277.
14. Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst. 2006;98(18): 1275-1284.
15. Dia VP, Berhow MA, Gonzalez De Mejia E. Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages. J Agric Food Chem. 2008;56(24):11707-11717.
16. Hämäläinen M, Nieminen R, Vuorela P, et al. Antiinflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-?B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-?B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007; 2007:45673. (doi:10.1155/2007/45673).
17. Lian F, Li Y, Bhuiyan M, et al. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer. 1999;33(2):125-131.
18. Lian F, Bhuiyan M, Li YW, et al. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a nonsmall-cell lung cancer cell line. Nutr Cancer. 1998;31(3): 184-191.
19. Whyte L, Huang YY, Torres K, et al. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007;67(24): 12007-12017.
20. Tallett A, Chilvers ER, Hannah S, et al. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Res. 1996;56(18):4255-4263.
21. Ryan-Borchers TA, Park JS, Chew BP, et al. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr. 2006;83(5):1118-1125.
22. Zou H, Zhan S, Cao K. Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed Pharmacother. 2008;62(9):583-589.
23. Menon LG, Kuttan R, Nair MG, et al. Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr Cancer. 1998;30(1):74-77.
24. Lee YS, Seo JS, Chung HT, et al. Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. J Korean Med Sci. 1991;6(4):325-328.
25. Gallo D, Zannoni GF, De Stefano I, et al. Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice. J Nutr. 2008;138(7):1360-1364.
26. Zheng W, Chow WH, Yang G, et al. The Shanghai Womens Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol. 2005;162(11):1123-1131.
27. Yang G, Shu XO, Li H, et al. Prospective cohort study of soy food intake and colorectal cancer risk in women. Am J Clin Nutr. 2009;89(2):577-583.
28. Shu XO, Yang G, Jin F, et al. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Womens Health Study. Eur J Clin Nutr. 2004;58(1): 17-23.
29. Yang YX, Wang GY, Pan XC, eds. China Food Composition Tables 2002. Beijing, China: Beijing University Medical Press; 2002.
30. Harrell FJ Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer-Verlag New York; 2001.
31. Collett D. Non-proportional hazards. In: Collett D, ed. Modelling Survival Data in Medical Research. 1st ed. New York, NY: Chapman & Hall, Inc; 1994:267-270.
32. Cai H, Shu XO, Gao YT, et al. A prospective study of dietary patterns and mortality in Chinese women. Epidemiology. 2007;18(3):393-401.
33. Pronk A, Coble J, Ji BT, et al. Occupational risk of lung cancer among lifetime non-smoking women in Shanghai, China. Occup Environ Med. 2009;66(10):672-678.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
35. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons, Inc; 1981.
36. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4(3): 218-228.
37. Egger M, Juni P, Bartlett C, et al. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess. 2003;7(1):1-76.